Program Description
Pediatric patients face elevated adverse drug reaction (ADR) risk due to immature and rapidly evolving physiology, frequent off-label medication use, and limited pediatric-specific clinical evidence. This activity examines the developmental pharmacokinetic and pharmacodynamic factors that heighten ADR risk across neonatal, infant, and pediatric age groups, and introduces the Key Potentially Inappropriate Drugs in Pediatrics (KIDs) List as a clinical decision-support tool for identifying medications and excipients that should be avoided or used with caution in children. Learners will also explore strategies for integrating KIDs List recommendations into health system workflows, including EHR-based clinical decision support and formulary optimization, to reduce preventable medication-related harm in pediatric patients.
Target audience: Community pharmacists and health system pharmacists
Type of activity: Application
Release date: July 1, 2026
Expiration date: July 1, 2027
Learner level: Foundational
Time to complete activity: 2.0 hours
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Examine developmental and pharmacologic factors that increase ADR risk in pediatric patients
- Apply the KIDs List to assess potentially inappropriate medications in pediatric patients
- Identify strategies to integrate the KIDs List into health system workflows
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
